Home › Research › Biomarkers
The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment
Fei M, Jianghua W, Rujuan M, Wei Z, Qian W.. Journal of the neurological sciences, 2011-03-26
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Amyloid β(Aβ) peptides are important components of plaques in Alzheimer's disease(AD). A decrease in the CSF concentration of Aβ40 and Aβ42 is a potential biomarker for incident AD. In contrast, studies on plasma Aβ40 and Aβ42 concentrations have yielded contradictory results. To explore the relationship between plasma Aβ40 and Aβ42 concentrations and AD in aging individuals with mild cognitive impairment (MCI), evaluate the sensitivity and the specificity of plasma Aβ and their ratio as a marker for progression to AD. We measured baseline concentrations of Aβ40 and Aβ42, and their ratio in plasma of patients carefully categorized clinically and neurochemically as having AD or other dementias from a cohort of patients with MCI (n=588) after 4-6 years of follow-up time. Plasma concentrations of Aβ40, Aβ42 were measured using a sandwich enzyme-linked immunosorbent assay technology. The association between plasma Aβ concentrations and the risk of dementia was assessed using Cox proportional hazard models. Optimal sensitivity and specificity of Aβ measurements were determined by ROC curve analysis. Plasma Aβ42 concentration and the Aβ42/Aβ40 ratio at baseline were significantly decreased in the MCI patients who developed AD as compared to cognitively stable MCI patients. The baseline concentrations of Aβ40 were similar in all MCI groups. The Aβ42/Aβ40 ratio was superior to Aβ42 concentration with regard to identify incipient AD in MCI. The ratio of Aβ42 to Aβ40 rather than absolute levels of the peptides can aid in the identification of incipient AD among MCI patients. A potential role of plasma Aβ concentrations as a marker of incipient dementia warrants further investigation.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Fei, M., Jianghua, W., Rujuan, M., Wei, Z., & Qian, W. (2011). The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment. Journal of the neurological sciences. https://doi.org/10.1016/j.jns.2011.03.005
Vancouver
Fei M, Jianghua W, Rujuan M, Wei Z, Qian W. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment. Journal of the neurological sciences. 2011. doi:10.1016/j.jns.2011.03.005. PMID: 21440911.
BibTeX
@article{fei2011-21440911,
author = {Fei, M. and Jianghua, W. and Rujuan, M. and Wei, Z. and Qian, W.},
title = {{The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment}},
journal = {Journal of the neurological sciences},
year = {2011},
doi = {10.1016/j.jns.2011.03.005},
pmid = {21440911},
url = {https://doi.org/10.1016/j.jns.2011.03.005}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- In contrast, studies on plasma Aβ40 and Aβ42 concentrations have yielded contradictory results.
- Plasma Aβ42 concentration and the Aβ42/Aβ40 ratio at baseline were significantly decreased in the MCI patients who developed AD as compared to cognitively stable MCI patients.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants588
- Evidence strengthModerate
How this study scored 48/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 28 of the 58 points we could judge it on, which is 48 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of the neurological sciences) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2011 — within 20 year(s) of the newest study here |
| Sample size | 2 / 4 | 588 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 21440911) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 28 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 28 of the 58 points we could judge it on is 48 out of 100. |
| Total | 48 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “individuals”
5 studies in the library carry the topic tag “individuals”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 5 tagged studies.